Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3 trial data
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,460 | Dovepress* | 7,160+ | 1,112 | 8,272 | |
| PubMed Central* | 1,300 | 464 | 1,764 | ||
| Totals | 8,460 | 1,576 | 10,036 | ||
| *Since 20 March 2019 | |||||
View citations on PubMed and Google Scholar